222 related articles for article (PubMed ID: 25123078)
21. Concurrent radiochemotherapy of locally recurrent or advanced sarcomas of the uterus.
Kortmann B; Reimer T; Gerber B; Klautke G; Fietkau R
Strahlenther Onkol; 2006 Jun; 182(6):318-24. PubMed ID: 16703286
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
Gadducci A; Romanini A
Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
[TBL] [Abstract][Full Text] [Related]
23. Manifestation of an undifferentiated uterine sarcoma in a 51 years old patient and its prognosis: A case report.
Pantelić M; Gvozdenovic L; Panjković M; Stojić M; Stajić D; Petrić A; Trajković SP; Trenkić M; Simić D; Živadinović L; Živadinović A
Medicine (Baltimore); 2022 Dec; 101(52):e32552. PubMed ID: 36596037
[TBL] [Abstract][Full Text] [Related]
24. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
Tanaka K; Mizusawa J; Fukuda H; Araki N; Chuman H; Takahashi M; Ozaki T; Hiruma T; Tsuchiya H; Morioka H; Hatano H; Iwamoto Y
Jpn J Clin Oncol; 2015 Jun; 45(6):555-61. PubMed ID: 25838293
[TBL] [Abstract][Full Text] [Related]
25. Uterine/female genital sarcomas.
Hensley ML
Curr Treat Options Oncol; 2000 Jun; 1(2):161-8. PubMed ID: 12057054
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and treatment modalities in uterine sarcoma.
El Husseiny G; Al Bareedy N; Mourad WA; Mohamed G; Shoukri M; Subhi J; Ezzat A
Am J Clin Oncol; 2002 Jun; 25(3):256-60. PubMed ID: 12040283
[TBL] [Abstract][Full Text] [Related]
27. Update on treatment of uterine sarcoma.
Nam JH; Park JY
Curr Opin Obstet Gynecol; 2010 Feb; 22(1):36-42. PubMed ID: 19923988
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in the treatment of sarcomas in gynecology.
Lange SS; Novetsky AP; Powell MA
Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
[TBL] [Abstract][Full Text] [Related]
29. Uterine sarcoma 2008.
Lin JF; Slomovitz BM
Curr Oncol Rep; 2008 Nov; 10(6):512-8. PubMed ID: 18928666
[TBL] [Abstract][Full Text] [Related]
30. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
[TBL] [Abstract][Full Text] [Related]
31. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
32. On the apparent failure of adjuvant pelvic radiotherapy to improve survival for women with uterine sarcomas confined to the uterus.
Dusenbery KE; Potish RA; Argenta PA; Judson PL
Am J Clin Oncol; 2005 Jun; 28(3):295-300. PubMed ID: 15923804
[TBL] [Abstract][Full Text] [Related]
33. Uterine sarcoma. Clinico-pathological characteristics and outcome.
Sait HK; Anfinan NM; El Sayed ME; Alkhayyat SS; Ghanem AT; Abayazid RM; Sait KH
Saudi Med J; 2014 Oct; 35(10):1215-22. PubMed ID: 25316466
[TBL] [Abstract][Full Text] [Related]
34. Advances in the diagnosis and treatment of uterine sarcomas.
Dizon DS; Birrer MJ
Discov Med; 2014 Jun; 17(96):339-45. PubMed ID: 24979254
[TBL] [Abstract][Full Text] [Related]
35. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival.
Gremel G; Liew M; Hamzei F; Hardell E; Selling J; Ghaderi M; Stemme S; Pontén F; Carlson JW
Int J Cancer; 2015 Apr; 136(7):1608-18. PubMed ID: 25130488
[TBL] [Abstract][Full Text] [Related]
36. [Chemotherapy and hormone therapy for uterine sarcomas].
Yamashita H; Arai H; Aoki D
Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
[TBL] [Abstract][Full Text] [Related]
37. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
[TBL] [Abstract][Full Text] [Related]
38. The treatment of uterine sarcomas.
Reichardt P
Ann Oncol; 2012 Sep; 23 Suppl 10():x151-7. PubMed ID: 22987952
[TBL] [Abstract][Full Text] [Related]
39. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Piver MS; Lele SB; Marchetti DL; Emrich LJ
J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
[TBL] [Abstract][Full Text] [Related]
40. Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.
Benson C; Ray-Coquard I; Sleijfer S; Litière S; Blay JY; Le Cesne A; Papai Z; Judson I; Schöffski P; Chawla S; Gil T; Piperno-Neumann S; Marréaud S; Dewji MR; van der Graaf WTA
Gynecol Oncol; 2016 Jul; 142(1):89-94. PubMed ID: 27012429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
